Biomexon Pharmaceuticals Private Limited
About Biomexon Pharmaceuticals Private Limited
Data last updated:
Biomexon Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2020PTC363490. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Vikram Kumar Thakur and Pooja Thakur.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at House No. 12 Sector 9 Landmark New 11 To 11 Restro Rohini, Delhi, India – 110085.
As per the financials filed for FY 2021, the company reported a revenue of ₹1.66 Cr. For the same year it recorded a net loss of ₹6,383 (net margin 0%) and EBITDA of -₹2,114 (EBITDA margin 0%).
Company details
Contact details
Biomexon Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressHouse No. 12 Sector 9 Landmark New 11 To 11 Restro Rohini, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biomexon Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biomexon Pharmaceuticals Private Limited, buy the company report.
Financials of Biomexon Pharmaceuticals Private Limited
FY 2021 filings availableBiomexon Pharmaceuticals Private Limited reported revenue of ₹1.66 Cr for FY 2021.
Financial Statement Summary
| Metrics | FY 2020-21 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹2,114 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹6,383 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2020-21 |
|---|---|
| Profitability | |
| EBITDA Margin | 0% |
| Net Profit Margin | 0% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Biomexon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Biomexon Pharmaceuticals Private Limited
Biomexon Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikram Kumar Thakur | Director | 05 Dec 2020 | 5 Years 10 Months | Current |
| Pooja Thakur | Director | 29 Apr 2020 | 6 Years 6 Months | Current |
| Asha Devi Also directs: Apsd House Private Limited, Saiman Life Sciences Private Limited | Additional Director | 16 Aug 2021 | 5 Years 2 Months | Current |
Peer comparison
Biomexon Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ratchet Pharma Private Limited | ₹1.66 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Kinsap Medisciences Private Limited | ₹1.66 Cr (FY 2025) | -36.0% | Green Park, Gujarat, India | |||
| Zerdia Healthcare Private Limited | ₹1.66 Cr (FY 2025) | -8.0% | Ambala Cantt, Haryana, India | |||
| Biomexon Pharmaceuticals Private Limitedthis company | ₹1.66 Cr (FY 2021) | -₹6,383 | 0% | Delhi, India | ||
| Siscon India Pvt Ltd | ₹1.65 Cr (FY 2024) | 7.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Biomexon Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biomexon Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biomexon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biomexon Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Biomexon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Biomexon Pharmaceuticals Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Rajeev Thakur Kumar ceased to be Director on 20 Sep 2021.
Frequently asked questions
Biomexon Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 April 2020 (6+ years old) and is registered under CIN U24100DL2020PTC363490.
Biomexon Pharmaceuticals has 3 current directors:
- Vikram Kumar Thakur - Director
- Pooja Thakur - Director
- Asha Devi - Additional Director
The latest financial statements of Biomexon Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2021 are in the company report.
No. Biomexon Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Biomexon Pharmaceuticals is U24100DL2020PTC363490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biomexon Pharmaceuticals was incorporated on 29 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Biomexon Pharmaceuticals by revenue are Ratchet Pharma Private Limited, Kinsap Medisciences Private Limited, Zerdia Healthcare Private Limited, Siscon India Pvt Ltd, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Rajeev Thakur Kumar ceased to be Director on 20 Sep 2021. Asha Devi was appointed as Additional Director on 16 Aug 2021. Vikram Kumar Thakur was appointed as Director on 05 Dec 2020. Biomexon Pharmaceuticals has 4 board changes on record in total.
The registered office of Biomexon Pharmaceuticals is at House No. 12 Sector 9 Landmark New 11 To 11 Restro Rohini, Delhi, India – 110085.
Biomexon Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Biomexon Pharmaceuticals can be reached at its registered office: House No. 12 Sector 9 Landmark New 11 To 11 Restro Rohini, Delhi, India – 110085.